France Menopause Market Size & Outlook, 2022-2030
France menopause market, 2018-2030 (US$M)
Related Markets
France menopause market highlights
- The France menopause market generated a revenue of USD 417.4 million in 2022 and is expected to reach USD 620.0 million by 2030.
- The France market is expected to grow at a CAGR of 5.1% from 2023 to 2030.
- In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
- Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.
Menopause market data book summary
| Market revenue in 2022 | USD 417.4 million |
| Market revenue in 2030 | USD 620.0 million |
| Growth rate | 5.1% (CAGR from 2022 to 2030) |
| Largest segment | Dietary supplements |
| Fastest growing segment | Dietary Supplements |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | OTC pharma products, Dietary Supplements |
| Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Other key industry trends
- In terms of revenue, France accounted for 2.6% of the global menopause market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany menopause market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 452.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Menopause Market Scope
Menopause Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France menopause market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to menopause market will help companies and investors design strategic landscapes.
Dietary supplements was the largest segment with a revenue share of 93.22% in 2022. Horizon Databook has segmented the France menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
France is witnessing a gradual increase in adoption of dietary supplements for various health aspects. Information on the use of food supplements was first collected during the Second Individual and National Study on Food Consumption (INCA), conducted in 2006-07 and later during 2014-2015 for INCA 3. It revealed that the consumption of food supplements almost doubled between the two study periods.
The Directorate-General for Competition, Consumer Affairs and Fraud Control (DGCCRF), in February 2019, released an update regarding vitamin A concentration in dietary supplements for the general population. However, due to the association of higher concentration of vitamin A with hip fractures and osteoporosis in menopausal women, the change was not permitted for dietary supplements designed for menopausal women. The research-based design of supplements can help deliver desired results, increasing the credibility of products.
Reasons to subscribe to France menopause market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France menopause market databook
-
Our clientele includes a mix of menopause market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France menopause market , including forecasts for subscribers. This country databook contains high-level insights into France menopause market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France menopause market size, by treatment, 2018-2030 (US$M)
France Menopause Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
